Aridis: Harnessing Monoclonal Antibodies to Fight Infections
Aridis Pharmaceuticals is advancing multiple clinical stage monoclonal antibodies (mAbs) targeting bacteria that cause life-threatening infections such as ventilator associated pneumonia (VAP) and hospital acquired pneumonia (HAP), in addition to preclinical stage antiviral mAbs. The use of mAbs as anti-infective treatments represents an innovative therapeutic approach that harnesses the human immune system to fight infections and is designed to overcome the deficiencies associated with the current standard of care which is broad spectrum antibiotics. Such deficiencies include, but are not limited to, increasing drug resistance, short duration of efficacy, disruption of the normal flora of the human microbiome and lack of differentiation among current treatments. The mAb portfolio is complemented by a non-antibiotic novel mechanism small molecule anti-infective candidate being developed to treat lung infections in cystic fibrosis patients. Visit https://www.redchip.com/stocks/ARDS/ to learn more.
-
8:33
Dr. Nick Zyrowski
3 months agoHow To Starve Fat Cells (Not Your Body)
423 -
6:19
Kicking Mustang
1 day agoAirsoft Karens Caught on Camera..
201 -
7:47
Adam Does Rants
16 hours agoUse The Sidewalk, NOT The Road!
782 -
10:36
Fascinating Horror
1 day agoA Brief History of Planking Accidents | Fascinating Horror
5025 -
4:33
TheGetCanceledPodcast
12 hours agoThe GCP | Siempre Tequila Lightning Round | Trivia with Ryan Bensen
271 -
13:47
RealReaper
18 hours agoThe Acolyte Episode 5 Is Dumb
203 -
41:09
World Nomac
14 hours agoExploring the Shanghai City, China 🇨🇳
1.55K3 -
17:58
Degenerate Jay
15 hours agoWe'll Never Get A James Bond Game Like This Again?
1.72K -
7:45:03
SNEAKO
10 hours agoSNEAKO X MYRON DESKTOP STREAM!
126K97 -
2:57:04
GoodLawgic
9 hours agoThe Following Program: The Left is LOSING It and it is HILARIOUS
41.4K23